Please try another search
For the nine months ended 30 September 2015, Biosign Technologies Inc revenues decreased 25% to C$395K. Net income totaled C$4.5M vs. loss of C$6.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net Income reflects write-down of intangible asset decrease of 96% to C$119K (expense), General and administrative decrease of 29% to C$1.9M (expense).
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Revenue | 0.07 | 0.32 | 0.15 | 0.14 |
Gross Profit | 0.07 | 0.31 | 0.13 | 0.11 |
Operating Income | -1.19 | -2.38 | -1.09 | -1.66 |
Net Income | 6.69 | -2.15 | -0.91 | -2.81 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Assets | 4.07 | 6.28 | 7.2 | 7.56 |
Total Liabilities | 5.13 | 14.12 | 13.88 | 13.41 |
Total Equity | -1.06 | -7.84 | -6.68 | -5.86 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -2.99 | -1.04 | -0.53 | -3.26 |
Cash From Investing Activities | -0.2 | -0.15 | -0.06 | -1.73 |
Cash From Financing Activities | 3.37 | 1.13 | 0.53 | 5.09 |
Net Change in Cash | 0.18 | -0.06 | -0.06 | 0.11 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review